AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21872918 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 610
Study 19834016 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control (target 70 to 110 mg/dL)
Number of subjects: 74
Study 19834016 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose control (target 70 to 200 mg/dL)
Number of subjects: 74
Study 19834016 — intervention group
Group type: COMPARATOR
Intervention: Usual care (target 70 to 300 mg/dL)
Number of subjects: 74
Study 17452068 — intervention group
Group type: EXPERIMENTAL
Intervention: M-AID mobile phone application
Number of subjects: 119
Study 17452068 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile phone support)
Number of subjects: 119
Study 12067330 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM anti-GM1 antibodies in patients with PD (detection via ELISA, initial dilution 1:800, positive at absorbance > 0.05)
Number of subjects: 147
Study 12067330 — intervention group
Group type: COMPARATOR
Intervention: IgM anti-GM1 antibodies in normal controls (detection via ELISA, initial dilution 1:800, positive at absorbance > 0.05)
Number of subjects: 147
Study 12067330 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG anti-GM1 antibodies in patients with PD (detection via ELISA, initial dilution 1:200, positive at absorbance > 0.1)
Number of subjects: 147
Study 12067330 — intervention group
Group type: COMPARATOR
Intervention: IgG anti-GM1 antibodies in normal controls (detection via ELISA, initial dilution 1:200, positive at absorbance > 0.1)
Number of subjects: 147
Study 9486993 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 470
Study 9486993 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 470
Study 8536896 — intervention group
Group type: EXPERIMENTAL
Intervention: C1 inhibitor
Number of subjects: 40
Study 8536896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2244564 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol (ISA)
Number of subjects: 24
Study 2244564 — intervention group
Group type: EXPERIMENTAL
Intervention: propranolol (non‐ISA)
Number of subjects: 24
Study 2244564 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 681309 — intervention group
Group type: EXPERIMENTAL
Intervention: Halazepam
Number of subjects: 51
Study 681309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 30216237 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-amount, low-intensity exercise (LALI)
Number of subjects: 181
Study 30216237 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amount, low-intensity exercise (HALI)
Number of subjects: 181
Study 30216237 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amount, high-intensity exercise (HAHI)
Number of subjects: 181
Study 30216237 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study 27542442 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT+NRT+CM
Number of subjects: 0
Study 27542442 — intervention group
Group type: COMPARATOR
Intervention: CBT+NRT
Number of subjects: 0
Study 25889758 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally-enhanced learning modules
Number of subjects: 127
Study 25889758 — intervention group
Group type: COMPARATOR
Intervention: Standard learning modules
Number of subjects: 127
Study 25889758 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formats (standard and enhanced)
Number of subjects: 127
Study 23485788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy
Number of subjects: 20
Study 23485788 — intervention group
Group type: COMPARATOR
Intervention: Intravesical dimethyl sulfoxide (DMSO)
Number of subjects: 20
Study 20298505 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes present
Number of subjects: 315
Study 19583647 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening during bed rest (n = 20)
Number of subjects: 40
Study 19583647 — intervention group
Group type: COMPARATOR
Intervention: Bed rest only (n = 20)
Number of subjects: 40
Study 17019406 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 17019406 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy female volunteers without a family history of depression)
Number of subjects: 0
Study 15202814 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended daily dialysis (EDD)
Number of subjects: 54
Study 15202814 — intervention group
Group type: COMPARATOR
Intervention: Continuous hemodialysis (CHD)
Number of subjects: 54
Study 11840808 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at 10.00
Number of subjects: 70
Study 11840808 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at 13.00
Number of subjects: 70
Study 11840808 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at other hours (7.00, 16.00, 19.00, 22.00)
Number of subjects: 70
Study 9949668 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg daily, increasing to 2-3 tablets based on metabolic control)
Number of subjects: 60
Study 9949668 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (24 units subcutaneously, adjusted based on metabolic response)
Number of subjects: 60
Study 9949668 — intervention group
Group type: COMPARATOR
Intervention: Controlled diet (in non-diabetic obese patients)
Number of subjects: 60
Study 7815986 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli preparation (Mutaflor)
Number of subjects: 70
Study 7815986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 31761120 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for dust mite
Number of subjects: 0
Study 31761120 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for latex
Number of subjects: 0
Study 31761120 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for venom hypersensitivity
Number of subjects: 0
Study 31351679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil during induction of remifentanil-based total intravenous anesthesia
Number of subjects: 40
Study 31351679 — intervention group
Group type: COMPARATOR
Intervention: Control group (remifentanil-based total intravenous anesthesia without sufentanil)
Number of subjects: 40
Study 27677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression score increase
Number of subjects: 228
Study 27677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety score increase
Number of subjects: 228
Study 27677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Likely anxiety category
Number of subjects: 228
Study 25925891 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent administration of abiraterone acetate plus prednisone (AA + P)
Number of subjects: 69
Study 25925891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential administration of abiraterone acetate plus prednisone (AA + P)
Number of subjects: 69
Study 25925891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Number of subjects: 69
Study 25925891 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sipuleucel-T with AA + P
Number of subjects: 69
Study 23557454 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowering program (twice a week for 60 minutes over 6 weeks)
Number of subjects: 46
Study 21822750 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐year internet‐based weight loss intervention
Number of subjects: 441
Study 21822750 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐year internet‐based weight loss intervention (high tertile participation)
Number of subjects: 441
Study 19689759 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 3640
Study 19689759 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 3640
Study 19689759 — intervention group
Group type: COMPARATOR
Intervention: State-of-the-art conservative treatment
Number of subjects: 3640
Study 16963365 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual hyperinflation (MHI)
Number of subjects: 14
Study 16963365 — intervention group
Group type: COMPARATOR
Intervention: Ventilator hyperinflation (VHI)
Number of subjects: 14
Study 15589436 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot orthotics
Number of subjects: 16
Study 11203746 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized biasing statement
Number of subjects: 40
Study 11203746 — intervention group
Group type: COMPARATOR
Intervention: No biasing statement (Control)
Number of subjects: 40
Study 9484514 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal (Disgren), 900 mg/day (300 mg 3 times a day)
Number of subjects: 217
Study 9484514 — intervention group
Group type: COMPARATOR
Intervention: AAS (Sedergine) 330 mg/day (once a day)
Number of subjects: 217
Study 8147246 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel
Number of subjects: 61
Study 8147246 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 micrograms gestodene
Number of subjects: 61
Study 3530368 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 40
Study 3530368 — intervention group
Group type: COMPARATOR
Intervention: Inactive TENS (Control)
Number of subjects: 40
Study 31821716 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) treatment for chronic HCV infection
Number of subjects: 101
Study 31821716 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) treatment
Number of subjects: 101
Study 29227175 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis HN019 (1 × 109 CFU/day)
Number of subjects: 228
Study 29227175 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis HN019 (1 × 1010 CFU/day)
Number of subjects: 228
Study 29227175 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis HN019 (combined high and low dose)
Number of subjects: 228
Study 29227175 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis HN019 (high-dose)
Number of subjects: 228
Study 26880227 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride (2 mg/day)
Number of subjects: 110
Study 26880227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 24183868 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative concurrent radiochemotherapy (POCRT) with paclitaxel (175 mg/m²) and cisplatin (60 mg/m²) for four cycles, plus radiotherapy (50.4 Gy/28 fractions) concurrently with the first 2 cycles of chemotherapy.
Number of subjects: 135
Study 24183868 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (POCT) with paclitaxel (175 mg/m²) and cisplatin (60 mg/m²) for four cycles.
Number of subjects: 135
Study 24183868 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative concurrent radiochemotherapy (POCRT) for patients with ≥2 pN2 lymph nodes.
Number of subjects: 135
Study 21853265 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic dietary supplement (Lactobacillus acidophilus NCFM and lactitol, 10 g lactitol and 2×10^10 cells of probiotic bacteria, taken twice a day for 2 weeks)
Number of subjects: 51
Study 21853265 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 51
Study 20501489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent claudication
Number of subjects: 5011
Study 18377658 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide with zoledronic acid
Number of subjects: 24
Study 18377658 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid alone
Number of subjects: 24
Study 15955124 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1 g bd)
Number of subjects: 30
Study 15955124 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg bd)
Number of subjects: 30
Study 15955124 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 11823661 — intervention group
Group type: EXPERIMENTAL
Intervention: CADASIL individuals
Number of subjects: 17
Study 11823661 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 17
Study 11823661 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondisabled CADASIL individuals (Rankin score=0, n=9)
Number of subjects: 17
Study 10429603 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet released for hemostasis before wound closure
Number of subjects: 81
Study 10429603 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet not released until wound closure and compressive dressing applied
Number of subjects: 81
Study 7771999 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise (at least 30 minutes, at least 3 times weekly)
Number of subjects: 0
Study 7771999 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy pregnant women who did not do regular vigorous exercise)
Number of subjects: 0
Study 2268437 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative blood temperature of 20 degrees C
Number of subjects: 20
Study 2268437 — intervention group
Group type: COMPARATOR
Intervention: Operative blood temperature of 28 degrees C
Number of subjects: 20
Study 476908 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 95
Study 476908 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk-based formula
Number of subjects: 95
Study 476908 — intervention group
Group type: COMPARATOR
Intervention: Proprietary infant milk formula
Number of subjects: 95
Study 476908 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid foods introduced at 3.5 months
Number of subjects: 95
Study 30762770 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional acupuncture and placebo pills
Number of subjects: 208
Study 30762770 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupoints acupuncture and antidepressant (fluoxetine hydrochloride tablets)
Number of subjects: 208
Study 30762770 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 208
Study 28152332 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT (Pfizer)
Number of subjects: 322
Study 28152332 — intervention group
Group type: COMPARATOR
Intervention: MenPS (GSK Vaccines)
Number of subjects: 322
Study 25641237 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher maternal education
Number of subjects: 1347
Study 25641237 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher paternal education
Number of subjects: 1347
Study 25641237 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver employment
Number of subjects: 1347
Study 25641237 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of all three social advantages (higher maternal education, higher paternal education, caregiver employment)
Number of subjects: 1347
Study 24699550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary verapamil
Number of subjects: 46
Study 24699550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine
Number of subjects: 46
Study 24699550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 24699550 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 46
Study 23008300 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α‐2b
Number of subjects: 1256
Study 23008300 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1256
Study 18977787 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric Analgesia Wheel
Number of subjects: 52
Study 18977787 — intervention group
Group type: COMPARATOR
Intervention: BNF for children (BNFC)
Number of subjects: 52
Study 17537117 — intervention group
Group type: EXPERIMENTAL
Intervention: BioSeed-S treatment with compression therapy (3‐6 x 10(6)/mL autologous keratinocytes with fibrin sealant)
Number of subjects: 225
Study 17537117 — intervention group
Group type: COMPARATOR
Intervention: Standard care with compression therapy
Number of subjects: 225
Study 17537117 — intervention group
Group type: EXPERIMENTAL
Intervention: BioSeed-S treatment with compression therapy
Number of subjects: 225
Study 15283821 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg x kg(‐1) rocuronium (group I)
Number of subjects: 44
Study 15283821 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg x kg(‐1) rocuronium (group II)
Number of subjects: 44
Study 11207468 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group R/P)
Number of subjects: 50
Study 11207468 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (group R/D)
Number of subjects: 50
Study 9471087 — intervention group
Group type: EXPERIMENTAL
Intervention: Safer Choices program
Number of subjects: 0
Study 9471087 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8517168 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 336
Study 8517168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 3429698 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg each morning for five doses)
Number of subjects: 30
Study 3429698 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg tid for 12 doses)
Number of subjects: 30
Study 3429698 — intervention group
Group type: EXPERIMENTAL
Intervention: Itazigrel (25 mg each morning for five doses)
Number of subjects: 30
Study 3429698 — intervention group
Group type: EXPERIMENTAL
Intervention: Itazigrel (50 mg tid for 12 doses)
Number of subjects: 30
Study 3429698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29345426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM) 1000 mg
Number of subjects: 50
Study 29345426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 50
Study 26729330 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine meditation intervention (2 hours/week of online meditation in a group setting led by a trainer, plus 1 hour/week of individual exercises)
Number of subjects: 120
Study 26729330 — intervention group
Group type: COMPARATOR
Intervention: Psycho‐education online program (control condition)
Number of subjects: 120
Study 26729330 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine meditation intervention
Number of subjects: 120
Study 23389902 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction in underweight patients
Number of subjects: 335
Study 23389902 — intervention group
Group type: COMPARATOR
Intervention: TRAM flap breast reconstruction in normal weight patients
Number of subjects: 335
Study 23389902 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction in both groups
Number of subjects: 335
Study 23209728 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week clevudine therapy
Number of subjects: 50
Study 19907913 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT
Number of subjects: 300
Study 19907913 — intervention group
Group type: COMPARATOR
Intervention: TVT-O
Number of subjects: 300
Study 17347074 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (5 mg administered via venous cannula)
Number of subjects: 64
Study 17347074 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (25 mg administered via venous cannula)
Number of subjects: 64
Study 15448121 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained hypoxia
Number of subjects: 0
Study 15448121 — intervention group
Group type: COMPARATOR
Intervention: Cyclic hypoxia
Number of subjects: 0
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Red palm oil (5 ml)
Number of subjects: 6
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Red palm oil (10 ml)
Number of subjects: 6
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground nut oil fortified with 400 retinol equivalent retinol palmitate
Number of subjects: 6
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground nut oil fortified with 800 retinol equivalent retinol palmitate
Number of subjects: 6
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground nut oil (5 ml)
Number of subjects: 6
Study 11871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground nut oil (10 ml)
Number of subjects: 6
Study 9884318 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 20
Study 9884318 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg granisetron
Number of subjects: 20
Study 8772213 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (IPG)
Number of subjects: 495
Study 8772213 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression ultrasonography (CUS)
Number of subjects: 495
Study 2252183 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 2252183 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 60
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg digoxin intravenously
Number of subjects: 9
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg digoxin intravenously
Number of subjects: 9
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg digoxin intravenously
Number of subjects: 9
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin intravenously every 24 hr for 10 consecutive days
Number of subjects: 9
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose digoxin therapy
Number of subjects: 9
Study 7408393 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose kinetics
Number of subjects: 9
Study 31843695 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery group
Number of subjects: 669
Study 31843695 — intervention group
Group type: COMPARATOR
Intervention: Control group (BMI >40 kg/m2 without bariatric surgery)
Number of subjects: 669
Study 30702059 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (765 mg)
Number of subjects: 300
Study 30702059 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard oral naltrexone (2 x 50 mg on Monday and Wednesday; 3 x 50 mg on Friday for 4 weeks, then patient-administered for 8 weeks)
Number of subjects: 300
Study 30702059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300